MCAS diagnosis in the UK: the NHS pathway, private routes and what to ask for

What MCAS is

Mast Cell Activation Syndrome (MCAS) is a condition in which mast cells — the immune cells responsible for allergic and anaphylactic reactions — release histamine, tryptase, prostaglandins and other mediators inappropriately, in response to triggers that wouldn't normally provoke a reaction. The result is recurrent, multi-system symptoms: flushing, urticaria, abdominal pain and diarrhoea, brain fog, tachycardia, presyncope, and in severe cases anaphylaxis.

It sits in the same family as systemic mastocytosis (where there are too many mast cells) and idiopathic anaphylaxis. Unlike mastocytosis, in MCAS the number of mast cells is usually normal — the problem is that they are easily and inappropriately activated.

The diagnostic criteria

The international consensus criteria (Valent et al., 2012, updated 2019) require all three of:

• Typical clinical features — recurrent, episodic symptoms affecting at least two organ systems consistent with mast cell mediator release.
• Objective evidence of mast cell mediator release — most commonly a rise in serum tryptase of at least 20% above baseline plus 2 ng/mL, measured within 1–4 hours of a symptomatic episode.
• Response to mast-cell-directed therapy — symptoms improve with H1 and H2 antihistamines, mast cell stabilisers (sodium cromoglicate), or leukotriene receptor antagonists.

Meeting one or two of those is not enough for a formal diagnosis under the consensus criteria — and many UK immunologists are strict about this.

The NHS route to a diagnosis

There is no single national NHS pathway for MCAS, but the practical route looks like this:

• GP appointment — document symptoms, triggers, organ systems involved, and timing.
• Baseline blood work at the GP: serum tryptase, total IgE, full blood count, vitamin D, basic metabolic panel.
• Referral to NHS adult immunology or allergy — typically at a teaching hospital that runs a mast cell service. UCLH (London), the Royal Brompton, Cambridge, Manchester and Salford are commonly cited.
• Specialist assessment — repeat tryptase, KIT D816V genetic test to rule out clonal mast cell disease, and a structured trial of treatment.

Waiting times for NHS immunology vary from 4 months to over 18 months by region. NHS Right to Choose may let you choose a different NHS-contracted provider with a shorter list.

The tests to ask for

• Baseline serum tryptase, taken when you are well.
• Acute serum tryptase, taken within 1–4 hours of a flare (this is the key test — most diagnoses fail because no-one ever captures it).
• 24-hour urinary N-methylhistamine and 11β-prostaglandin F2α at specialist centres.
• KIT D816V genetic test on peripheral blood, to look for clonal mast cell disease.
• Specific IgE to suspected triggers, ruling out classical IgE-mediated allergy.

The single most important practical step is having a plan for the acute tryptase. Ask your GP for a phlebotomy form already filled out and held at the practice, so that when a flare happens you can walk in and have blood taken within the 1–4-hour window.

Private routes

If NHS waits are intolerable, a private consultation with an NHS-trained immunologist is the fastest route. Expect £250–£600 for the initial appointment plus laboratory costs (~£70–£150 for tryptase and related panels). Specialist private mast cell services exist in London, Manchester and Cambridge. A private diagnosis is recognised by the NHS as long as the consultant is GMC-registered and willing to write back to your GP.

What to ask your GP for, in writing

A short written request is much harder to deflect than a verbal one in a 10-minute appointment. At minimum, ask the GP for:

• Baseline serum tryptase, total IgE, FBC and vitamin D.
• A standing phlebotomy form for acute tryptase during a flare.
• Referral to NHS adult immunology or allergy, citing the international consensus criteria for MCAS.
• If applicable, a Right to Choose referral to an NHS-contracted mast cell service with a shorter wait.
• A trial of H1 and H2 antihistamines (e.g. fexofenadine 180mg twice daily + famotidine 20mg twice daily) while waiting, as both diagnostic and therapeutic.

If your GP refuses to investigate at all, your situation is now about being heard, not about MCAS specifically. See our guide on what to do when your GP won't listen. Our £49 formal letter sets out your symptoms, the relevant NICE guidance on suspected allergic / immunological disease, the GMC duty to refer when clinically appropriate, and a numbered set of requests — added to your medical record with a 28-day deadline for a written response.

After diagnosis

A formal MCAS diagnosis usually unlocks: a written management plan, prescription antihistamines and mast cell stabilisers, an EpiPen for anaphylaxis risk, trigger-avoidance advice, and access to disability protections under the Equality Act 2010 where the impact qualifies. Keep a copy of your specialist's diagnostic letter — it's the document everyone (insurer, employer, university, A&E) will ask for.

Frequently asked questions